MedPath

A study to compare the effect of two forms of pain relieving drug -morphine( immediate release morphine and controlled release morphine) in advanced cancer patients.

Not Applicable
Completed
Conditions
Health Condition 1: null- Advanced stage cancer patients who are suffering due to pain
Registration Number
CTRI/2017/09/009817
Lead Sponsor
JIPMER
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
70
Inclusion Criteria

All cancer patients enrolled in JIPMER Palliative Clinic at Regional Cancer Centre (RCC), whose pain is controlled with morphine 60 mg/day and higher dose.

Exclusion Criteria

1.Patients < 18 years of age.

2.Elderly patients who are bedridden.

3.Patients who are hearing impaired, visually impaired & aphasic.

4.Patients who are on other pain medications with morphine.

5.Patients who require other treatments like irradiation, nerve blocks, epidural anesthesia etc., for their pain management along with morphine.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Pain intensity measured using visual analog scale and Brief pain inventory questionnaire at 3weeks <br/ ><br>2. Plasma morphine and its metabolites concentration using Liquid chromatography - Mass Spectrometry <br/ ><br>Timepoint: One and half years <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
1.Side effects developed during the treatment <br/ ><br>2.Total dose of morphine required for each formulation. <br/ ><br>3.Total cost of each phase of treatment per patient. <br/ ><br>4.No. of rescue doses of morphine required. <br/ ><br> <br/ ><br>Timepoint: One and half years
© Copyright 2025. All Rights Reserved by MedPath